Point of Care Testing Market Size, Share, and Trends 2025 to 2034

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Point-of-Care Testing (POCT) Market 

5.1. COVID-19 Landscape: Point-of-Care Testing (POCT) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Point-of-Care Testing (POCT) Market, By Product Type

8.1. Point-of-Care Testing (POCT) Market, by Product Type

8.1.1. Covid -19 testing kits

8.1.1.1. Market Revenue and Forecast

8.1.2. Glucose monitoring products

8.1.2.1. Market Revenue and Forecast

8.1.3. Cardiometabolic Monitoring Products

8.1.3.1. Market Revenue and Forecast

8.1.4. Infectious disease testing products

8.1.4.1. Market Revenue and Forecast

8.1.5. Coagulation monitoring products

8.1.5.1. Market Revenue and Forecast

8.1.6. Pregnancy and fertility testing products

8.1.6.1. Market Revenue and Forecast

8.1.7. Pregnancy testing products

8.1.7.1. Market Revenue and Forecast

8.1.8. Fertility testing products

8.1.8.1. Market Revenue and Forecast

8.1.9. Cancer marker testing products

8.1.9.1. Market Revenue and Forecast

8.1.10. Urinanalysis testing products

8.1.10.1. Market Revenue and Forecast

8.1.11. Cholestrol testing products

8.1.11.1. Market Revenue and Forecast

8.1.12. Hematology testing products

8.1.12.1. Market Revenue and Forecast

8.1.13. Drugs-of-abuse testing products

8.1.13.1. Market Revenue and Forecast

8.1.14. Fecal Occult testing products

8.1.14.1. Market Revenue and Forecast

8.1.15. Others

8.1.15.1. Market Revenue and Forecast

Chapter 9. Global Point-of-Care Testing (POCT) Market, By Platform

9.1. Point-of-Care Testing (POCT) Market, by Platform

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Forecast

9.1.2. Dipsticks

9.1.2.1. Market Revenue and Forecast

9.1.3. Microfluids

9.1.3.1. Market Revenue and Forecast

9.1.4. Molecular Diagnostics

9.1.4.1. Market Revenue and Forecast

9.1.5. Immunoassays

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Point-of-Care Testing (POCT) Market, By Mode of Purchase 

10.1. Point-of-Care Testing (POCT) Market, by Mode of Purchase

10.1.1. OTC products

10.1.1.1. Market Revenue and Forecast

10.1.2. Prescribed based products

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Point-of-Care Testing (POCT) Market, By Testing Type

11.1. Point-of-Care Testing (POCT) Market, by Testing Type

11.1.1. Immunoassays

11.1.1.1. Market Revenue and Forecast

11.1.2. Cell-Based Assays

11.1.2.1. Market Revenue and Forecast

11.1.3. Nucleic Acid Amplification Testing

11.1.3.1. Market Revenue and Forecast

11.1.4. Clinical Chemistry Assays

11.1.4.1. Market Revenue and Forecast

11.1.5. Hematology

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Point-of-Care Testing (POCT) Market, By End-User

12.1. Point-of-Care Testing (POCT) Market, by End-User

12.1.1. Clinical laboratories

12.1.1.1. Market Revenue and Forecast

12.1.2. Ambulatory care facilities and physician offices

12.1.2.1. Market Revenue and Forecast

12.1.3. Pharmacies, retail clinics & E-comm platforms

12.1.3.1. Market Revenue and Forecast

12.1.4. Hospitals, Critical care centres, Urgent care centres

12.1.4.1. Market Revenue and Forecast

12.1.5. Home care & self-testing

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global Point-of-Care Testing (POCT) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type

13.1.2. Market Revenue and Forecast, by Platform

13.1.3. Market Revenue and Forecast, by Mode of Purchase

13.1.4. Market Revenue and Forecast, by Testing Type

13.1.5. Market Revenue and Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type

13.1.6.2. Market Revenue and Forecast, by Platform

13.1.6.3. Market Revenue and Forecast, by Mode of Purchase

13.1.6.4. Market Revenue and Forecast, by Testing Type

13.1.6.5. Market Revenue and Forecast, by End-User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type

13.1.7.2. Market Revenue and Forecast, by Platform

13.1.7.3. Market Revenue and Forecast, by Mode of Purchase

13.1.7.4. Market Revenue and Forecast, by Testing Type

13.1.7.5. Market Revenue and Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type

13.2.2. Market Revenue and Forecast, by Platform

13.2.3. Market Revenue and Forecast, by Mode of Purchase

13.2.4. Market Revenue and Forecast, by Testing Type

13.2.5. Market Revenue and Forecast, by End-User

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type

13.2.6.2. Market Revenue and Forecast, by Platform

13.2.6.3. Market Revenue and Forecast, by Mode of Purchase

13.2.7. Market Revenue and Forecast, by Testing Type

13.2.8. Market Revenue and Forecast, by End-User

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type

13.2.9.2. Market Revenue and Forecast, by Platform

13.2.9.3. Market Revenue and Forecast, by Mode of Purchase

13.2.10. Market Revenue and Forecast, by Testing Type

13.2.11. Market Revenue and Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type

13.2.12.2. Market Revenue and Forecast, by Platform

13.2.12.3. Market Revenue and Forecast, by Mode of Purchase

13.2.12.4. Market Revenue and Forecast, by Testing Type

13.2.13. Market Revenue and Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type

13.2.14.2. Market Revenue and Forecast, by Platform

13.2.14.3. Market Revenue and Forecast, by Mode of Purchase

13.2.14.4. Market Revenue and Forecast, by Testing Type

13.2.15. Market Revenue and Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type

13.3.2. Market Revenue and Forecast, by Platform

13.3.3. Market Revenue and Forecast, by Mode of Purchase

13.3.4. Market Revenue and Forecast, by Testing Type

13.3.5. Market Revenue and Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type

13.3.6.2. Market Revenue and Forecast, by Platform

13.3.6.3. Market Revenue and Forecast, by Mode of Purchase

13.3.6.4. Market Revenue and Forecast, by Testing Type

13.3.7. Market Revenue and Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type

13.3.8.2. Market Revenue and Forecast, by Platform

13.3.8.3. Market Revenue and Forecast, by Mode of Purchase

13.3.8.4. Market Revenue and Forecast, by Testing Type

13.3.9. Market Revenue and Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type

13.3.10.2. Market Revenue and Forecast, by Platform

13.3.10.3. Market Revenue and Forecast, by Mode of Purchase

13.3.10.4. Market Revenue and Forecast, by Testing Type

13.3.10.5. Market Revenue and Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type

13.3.11.2. Market Revenue and Forecast, by Platform

13.3.11.3. Market Revenue and Forecast, by Mode of Purchase

13.3.11.4. Market Revenue and Forecast, by Testing Type

13.3.11.5. Market Revenue and Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type

13.4.2. Market Revenue and Forecast, by Platform

13.4.3. Market Revenue and Forecast, by Mode of Purchase

13.4.4. Market Revenue and Forecast, by Testing Type

13.4.5. Market Revenue and Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type

13.4.6.2. Market Revenue and Forecast, by Platform

13.4.6.3. Market Revenue and Forecast, by Mode of Purchase

13.4.6.4. Market Revenue and Forecast, by Testing Type

13.4.7. Market Revenue and Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type

13.4.8.2. Market Revenue and Forecast, by Platform

13.4.8.3. Market Revenue and Forecast, by Mode of Purchase

13.4.8.4. Market Revenue and Forecast, by Testing Type

13.4.9. Market Revenue and Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type

13.4.10.2. Market Revenue and Forecast, by Platform

13.4.10.3. Market Revenue and Forecast, by Mode of Purchase

13.4.10.4. Market Revenue and Forecast, by Testing Type

13.4.10.5. Market Revenue and Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type

13.4.11.2. Market Revenue and Forecast, by Platform

13.4.11.3. Market Revenue and Forecast, by Mode of Purchase

13.4.11.4. Market Revenue and Forecast, by Testing Type

13.4.11.5. Market Revenue and Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type

13.5.2. Market Revenue and Forecast, by Platform

13.5.3. Market Revenue and Forecast, by Mode of Purchase

13.5.4. Market Revenue and Forecast, by Testing Type

13.5.5. Market Revenue and Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type

13.5.6.2. Market Revenue and Forecast, by Platform

13.5.6.3. Market Revenue and Forecast, by Mode of Purchase

13.5.6.4. Market Revenue and Forecast, by Testing Type

13.5.7. Market Revenue and Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type

13.5.8.2. Market Revenue and Forecast, by Platform

13.5.8.3. Market Revenue and Forecast, by Mode of Purchase

13.5.8.4. Market Revenue and Forecast, by Testing Type

13.5.8.5. Market Revenue and Forecast, by End-User

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Roche Diagnostics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Siemens Healthineers

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Johnson & Johnson

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Danaher Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Becton, Dickinson and Company (BD)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Philips Healthcare

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Sysmex Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quidel Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Chembio Diagnostics

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms